PuraPharm Corp. Ltd. (HK:1498) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
PuraPharm Corp. Ltd. has announced a change in its auditor, replacing Ernst & Young with BDO Limited, due to more competitive proposals that promise enhanced corporate governance and cost-effectiveness. This shift follows EY’s resignation over a disagreement on audit fees for the upcoming fiscal year. The company assures that the transition will not impact its annual audit for FY2024.
For further insights into HK:1498 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money